Cardinal Health Reports First-quarter Results for Fiscal Year 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Leerink Partners Cuts Price Target on Cardinal Health (CAH) Following 1Q
November 1, 2016 7:53 AM EDTLeerink Partners maintained an Outperform rating on Cardinal Health (NYSE: CAH), and cut the price target to $80.00 (from $95.00), following the company's 1Q earnings report. Leerink cut EPS estimates for 2017 and 2018 by ~$0.15 and ~$0.20, respectively, due to the headwinds in the Pharmaceutical Division. On the call management stated that in 2Q the... More
Cardinal Health (CAH) Tops Q1 EPS by 3c; Lowers Guidance
October 31, 2016 7:04 AM EDTCardinal Health (NYSE: CAH) reported Q1 EPS of $1.24, $0.03 better than the analyst estimate of $1.21. Revenue for the quarter came in at $32 billion versus the consensus estimate of $31.04 billion.
GUIDANCE:
Cardinal Health sees FY2017 EPS of $5.40-$5.60, versus prior guidance of... More
